Skip to main content
2023 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Integrated Informatics Institute
Back
Handout

Clinical Sessions for Recertification

Educational Sessions

Board Certification Activities

Changing the Way Patients Access Reproductive Healthcare

Tuesday, December 5, 2023
8:00 AM – 10:00 AM  
Location: ACC, Room 201b, Level 2
CE Credits 2.00 contact hours
Planned in cooperation with the American College of Clinical Pharmacy
Activity #: 0217-9999-23-077-L01-P
Activity Type: Application-based
Target Audience: Pharmacist, Board-Certified Pharmacist
NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

There are many barriers to access to Women's Health and contraception. This session will help to decrease those barriers by providing resources to help pharmacists advocate for the expansion of laws in their state to include pharmacist contraceptive services as well as to assist pharmacists in rolling out pharmacist contraceptive services if their state already has laws in place. For states with laws in place, the uptick has been low at times. By provided case-based examples and tools readily at their disposal, pharmacists will feel more empowered to establish or expand services to include Women's Health.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) recertification credit.

Learning Objectives:

  • Assess barriers to access to hormonal contraceptives.
  • Examine advocacy efforts to expand the pharmacist's role to prescribe hormonal contraceptives.
  • Compare and contrast key pharmacology differences between oral contraceptive types including new drug updates.
  • Apply tools and technology to determine patient eligibility for pharmacists to prescribe hormonal contraceptives.